APA

de Gramont A., Louvet C., Krulik M., Smadja N., Donadio D., Laporte J. P., Brissaud P., Delâge J. M., Drolet Y. & Rioux E. (19870226). Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease. : Cancer.

Chicago

de Gramont A, Louvet C, Krulik M, Smadja N, Donadio D, Laporte J P, Brissaud P, Delâge J M, Drolet Y and Rioux E. 19870226. Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease. : Cancer.

Harvard

de Gramont A., Louvet C., Krulik M., Smadja N., Donadio D., Laporte J. P., Brissaud P., Delâge J. M., Drolet Y. and Rioux E. (19870226). Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease. : Cancer.

MLA

de Gramont A, Louvet C, Krulik M, Smadja N, Donadio D, Laporte J P, Brissaud P, Delâge J M, Drolet Y and Rioux E. Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease. : Cancer. 19870226.